Enliven Therapeutics, Inc.
ELVN
37 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | Mar 18 9:22 PM | Kintz Samuel | Proposed Sale | 21,531 | $21.04 | $453.0K | — | View → |
| Mar 18, 2025 | Mar 18 8:14 PM | Kintz Samuel | Proposed Sale | 21,531 | $21.04 | $453.0K | — | View → |
| Mar 18, 2025 | Mar 18 8:06 PM | Kintz Samuel | Proposed Sale | 21,531 | $21.04 | $453.0K | — | View → |
| Mar 17, 2025 | Mar 17 8:14 PM | Kintz Samuel | Proposed Sale | 12,500 | $20.74 | $259.3K | — | View → |
| Mar 17, 2025 | Mar 17 8:08 PM | Patel Anish | Proposed Sale | 2,500 | $20.74 | $51.9K | — | View → |
| Mar 17, 2025 | Mar 17 8:04 PM | Patel Anish | Proposed Sale | 2,500 | $20.74 | $51.9K | — | View → |
| Mar 7, 2025 | Mar 7 9:18 PM | Patel Anish | Proposed Sale | 6,667 | $21.46 | $143.1K | — | View → |
| Feb 27, 2025 | Feb 27 9:10 PM | Hohl Benjamin | Proposed Sale | 4,250 | $20.28 | $86.2K | — | View → |
| Feb 14, 2025 | Feb 14 10:02 PM | Patel Anish | Proposed Sale | 2,500 | $21.50 | $53.8K | — | View → |
| Feb 14, 2025 | Feb 14 9:17 PM | Patel Anish | Proposed Sale | 2,500 | $21.50 | $53.8K | — | View → |
| Feb 7, 2025 | Feb 7 9:02 PM | Patel Anish | Proposed Sale | 6,667 | $22.47 | $149.8K | — | View → |
| Jan 27, 2025 | Jan 27 9:37 PM | Hohl Benjamin | Proposed Sale | 4,250 | $21.86 | $92.9K | — | View → |
| Jan 14, 2025 | Jan 14 9:06 PM | Patel Anish | Proposed Sale | 2,500 | $22.07 | $55.2K | — | View → |
| Jan 14, 2025 | Jan 14 9:01 PM | Patel Anish | Proposed Sale | 2,500 | $22.07 | $55.2K | — | View → |
| Jan 7, 2025 | Jan 7 9:21 PM | Patel Anish | Proposed Sale | 28,367 | $24.07 | $682.8K | — | View → |
| Jan 3, 2025 | Jan 3 9:05 PM | Hohl Benjamin | Proposed Sale | 1,000 | $23.90 | $23.9K | — | View → |
| Dec 27, 2024 | Dec 27 9:33 PM | Hohl Benjamin | Proposed Sale | 4,250 | $22.71 | $96.5K | — | View → |
| Dec 16, 2024 | Dec 16 9:30 PM | Patel Anish | Proposed Sale | 2,500 | $23.15 | $57.9K | — | View → |
| Dec 16, 2024 | Dec 16 9:15 PM | Patel Anish | Proposed Sale | 2,500 | $23.15 | $57.9K | — | View → |
| Nov 15, 2024 | Nov 15 9:35 PM | Patel Anish | Proposed Sale | 17,500 | $24.92 | $436.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 18 12:57 AM | Scott J. GarlandDirector | Grant/Award | 1,427 | $27.16 | 1,427(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Mika K DerynckDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Jake BauerDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:55 AM | Rahul D. BallalDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:53 AM | Anish PatelCHIEF OPERATING OFFICER | Grant/Award | 120,000 | $27.16 | 120,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:52 AM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Grant/Award | 112,500 | $27.16 | 112,500(D) | View → |
| Feb 12, 2026 | Feb 18 12:49 AM | Benjamin HohlCHIEF FINANCIAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:47 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
← Previous
Page 2 of 2